Telecommunication Technology-based Online Survey

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

December 31, 2026

Conditions
Risk FactorsPolypharmacyDrug InteractionsSelf MedicationCOVID-19
Interventions
OTHER

Online Survey

The participants of the study undergo the online survey at www.zdorov.tpu.ru and www.zdorov.expert.

DIAGNOSTIC_TEST

Genetic Testing

Genetic testing will be performed in subgroup of survey respondents willing to participate in the study of polymorphisms of genes involved in drug metabolism or affecting biological effects of medications including CYP2D6, ACE, UGT1A1, CYP2C9, and CYP2C19.

Trial Locations (1)

634012

RECRUITING

Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER